Search

You searched for "wellbeing"

1641 results found

Strabismus in thyroid eye disease

1 April 2017 | | EYE - Paediatrics, EYE - Strabismus
Pathogenesis Thyroid eye disease (TED) is an auto-immune condition, in the initial phase there is lymphocytic infiltration and oedema of the extraocular muscles with deposition of glycosaminoglycans and hyaluronic acid and adipogenesis, which can lead to an increase in the...

Deal With It card game

1 February 2019 | | EYE - General
‘Deal With It’ is a pack of scenario revision cards. The game is designed to act as a study and training aid for optical professionals. The rules allow a user to self-test or can be used in pairs or in...

The approach to angle-closure glaucoma

1 October 2016 | | EYE - Glaucoma
Further to my last article in Eye News (print issue) describing the diagnostic approaches to various clinical scenarios in glaucoma, the approach to angle-closure glaucoma (ACG), a situation terrifying for patient and registrar alike, will be discussed. Please refer to...

Forward-tilt technique for intraocular pressure measurement in upgaze

5 June 2020 | | EYE - Glaucoma, EYE - General
The authors suggest a technique to improve the accuracy of measuring IOP in upgaze using Goldmann applanation tonometry. Graves’ ophthalmopathy, also known as thyroid eye disease, is an autoimmune inflammatory condition affecting the orbit and periorbital tissues [1]. It was...

Four pillars: Exploring eye exigencies

2 June 2025 | | EYE - General
This series explores the four pillars of advanced clinical practice and here, Jem Ann Bautista explores the pillar of clinical practice. As day case theatre practitioners in one of London’s biggest and busiest centres, our team is trained to cater...

Managing a patient with ptosis

1 August 2015 | | EYE - Oculoplastic, EYE - Orbit
A 50-year-old male patient is referred from the Accident & Emergency department with a history of ptosis. How will you manage this patient? Mr Bertie Fernando Clinical management Clinical management starts with a sound clinical history. Current history The history...

Treatment of diabetic macular oedema

1 June 2014 | | EYE - Vitreo-Retinal
Diabetic macular oedema (DMO) is a common complication associated with diabetic retinopathy, and the most common cause of visual impairment in diabetes [1]. With predicted rising levels of diabetes (in England by 2025 the estimated population with diabetes will be...

Collaborating across the Caribbean to tackle diabetic retinopathy

1 December 2017 | | EYE - Vitreo-Retinal, EYE - General
The VISION 2020 LINKS Programme has been running since 2004, with a focus on improving the quality and quantity of eye care training in low-income countries [1]. In 2014, the Diabetic Retinopathy Network (DR-NET) was established [2]. This is a...

90% of NHS trusts now have electronic patient records

22 November 2023 | EPR, Digitalisation, NHS, Electronic patient records
The NHS has met the government’s target for 90% of trusts adopting electronic patient records (EPR) in hospitals ahead of schedule.

Birdshot retinochoroiditis

1 June 2022 | | EYE - Vitreo-Retinal, EYE - General
Birdshot retinochoroiditis (BRC) is a chronic, sight-threatening uveitis, most commonly affecting caucasian individuals in their fourth to sixth decades [1]. The disease is associated with HLA-29 and is characterised by progressive inflammation at the level of retina and choroid, with...

How good does my vision have to be to drive this thing? Visual standards for various occupations

2 August 2022 | | EYE - General
We can all picture that moment in clinic: you are about to tell someone that they’re no longer legally able to drive, ready to deploy our ‘breaking bad news’ techniques. For some patients this may have been expected, or they...

The results of the last survey Jun23

5 June 2023 | | EYE - General
*Please be aware that this data does not form part of a peer reviewed research study. The information therein should not be relied upon for clinical purposes but instead used as a guide for clinical practice and reflection. I continue...